Related references
Note: Only part of the references are listed.Recent advances in PTP1B signaling in metabolism and cancer
Olga Villamar-Cruz et al.
BIOSCIENCE REPORTS (2021)
Activation of PTP1B/EGFR signaling and cytotoxicity during combined exposure to ambient electrophiles in A431 cells
Yumi Abiko et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2021)
Redox toxicology of environmental chemicals causing oxidative stress
Fuli Zheng et al.
REDOX BIOLOGY (2020)
TGFβ and EGF signaling orchestrates the AP-1-and p63 transcriptional regulation of breast cancer invasiveness
Anders Sundqvist et al.
ONCOGENE (2020)
Potent and selective PTP1B inhibition by a platinum(ii) complex: possible implications for a new antitumor strategy
Caixia Yuan et al.
CHEMICAL COMMUNICATIONS (2020)
Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signaling
Romain Duval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
A structure-based mechanism of cisplatin resistance mediated by glutathione transferase P1-1
Anastasia De Luca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Perturbation of Iron Metabolism by Cisplatin through Inhibition of Iron Regulatory Protein 2
Masaki Miyazawa et al.
CELL CHEMICAL BIOLOGY (2019)
Fate of cisplatin and its main hydrolysed forms in the presence of thiolates: a comprehensive computational and experimental study
Thibault Minervini et al.
METALLOMICS (2019)
Increasing the low lipid phosphate phosphatase 1 activity in breast cancer cells decreases transcription by AP-1 and expressions of matrix metalloproteinases and cyclin D1/D3
Xiaoyun Tang et al.
THERANOSTICS (2019)
Identification of cisplatin-binding sites on the large cytoplasmic loop of the Na+/K+-ATPase
Jaroslava Seflova et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Targeting an oncogenic kinase/phosphatase signaling network for cancer therapy
Xiao-Mei Qi et al.
Acta Pharmaceutica Sinica B (2018)
Deficiency in Protein Tyrosine Phosphatase PTP1B Shortens Lifespan and Leads to Development of Acute Leukemia
Samantha Le Sommer et al.
CANCER RESEARCH (2018)
Deletion of Ptpn1 induces myeloproliferative neoplasm
F. Jobe et al.
LEUKEMIA (2017)
TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies
Kelly A. Pike et al.
CYTOKINE (2016)
Redox-dependent regulation of epidermal growth factor receptor signaling
David E. Heppner et al.
REDOX BIOLOGY (2016)
Effect of cisplatin on proteasome activity
G. R. Tundo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
STAT1 Activation Is Enhanced by Cisplatin and Variably Affected by EGFR Inhibition in HNSCC Cells
Nicole C. Schmitt et al.
MOLECULAR CANCER THERAPEUTICS (2015)
A RP-UFLC Assay for Protein Tyrosine Phosphatases: Focus on Protein Tyrosine Phosphatase Non-Receptor Type 2 (PTPN2)
Romain Duval et al.
SCIENTIFIC REPORTS (2015)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Reactivation of oxidized PTP1B and PTEN by thioredoxin 1
Ulla Schwertassek et al.
FEBS JOURNAL (2014)
Cisplatin Binding to Proteins: Molecular Structure of the Ribonuclease A Adduct
Luigi Messori et al.
INORGANIC CHEMISTRY (2014)
Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma
Jay Gunawardana et al.
NATURE GENETICS (2014)
Pt-based drugs: the spotlight will be on proteins
O. Pinato et al.
METALLOMICS (2014)
Methods to monitor classical protein-tyrosine phosphatase oxidation
Robert Karisch et al.
FEBS JOURNAL (2013)
Protein tyrosine phosphatase structure-function relationships in regulation and pathogenesis
Frank Boehmer et al.
FEBS JOURNAL (2013)
Transcription Factor Interactions Mediate EGF-Dependent COX-2 Expression
Kaiming Xu et al.
MOLECULAR CANCER RESEARCH (2013)
DNA-Bound Platinum Is the Major Determinant of Cisplatin Sensitivity in Head and Neck Squamous Carcinoma Cells
Sanne R. Martens-de Kemp et al.
PLOS ONE (2013)
Covalent binding of cisplatin impairs the function of Na+/K+-ATPase by binding to its cytoplasmic part
Miroslav Huliciak et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Redox Regulation of Epidermal Growth Factor Receptor Signaling through Cysteine Oxidation
Thu H. Truong et al.
BIOCHEMISTRY (2012)
1,4-Naphthoquinones as inducers of oxidative damage and stress signaling in HaCaT human keratinocytes
Viola Klaus et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Role of Epidermal Growth Factor Receptor Degradation in Cisplatin-Induced Cytotoxicity in Head and Neck Cancer
Aarif Ahsan et al.
CANCER RESEARCH (2010)
PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice
Ryoichi Banno et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Targeted Quantitation of Site-Specific Cysteine Oxidation in Endogenous Proteins Using a Differential Alkylation and Multiple Reaction Monitoring Mass Spectrometry Approach
Jason M. Held et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Cisplatin Interaction with Cysteine and Methionine in Aqueous Solution: Computational DFT/PCM Study
Tomas Zimmermann et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2009)
Characterization of Novel Oxidation Products of Cysteine in an Active Site Motif Peptide of PTP1B
Vivekananda Shetty et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2009)
The anti-EGFR monoclonal antibody blocks cisplatin-induced activation of EGFR signaling mediated by HB-EGF
Takeshi Yoshida et al.
FEBS LETTERS (2008)
Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells:: Molecular and cellular mechanisms of inhibition
Nilusha Ragunathan et al.
MOLECULAR PHARMACOLOGY (2008)
Redox regulation of the protein tyrosine phosphatase PTP1B in cancer cells
Yi-Wei Lou et al.
FEBS JOURNAL (2008)
Kinetics and mechanism of protein tyrosine phosphatase 1B inactivation by acrolein
Derrick R. Seiner et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
Redox regulation of protein tyrosine phosphatase 1B by peroxymonophosphate (-O3POOH)
Jason N. LaButti et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Speciation analysis of platinum antitumoral drugs in impacted tissues
D. Esteban-Fernandez et al.
TALANTA (2007)
Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis
Sofi G. Julien et al.
NATURE GENETICS (2007)
Protein tyrosine phosphatase function: the substrate perspective
Tony Tiganis et al.
BIOCHEMICAL JOURNAL (2007)
Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer
Kevin J. Cullen et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2007)
Protein tyrosine phosphatases: from genes, to function, to disease
Nicholas K. Tonks
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
PTP1B and TC-PTP: novel roles in immune-cell signaling
Paul D. Simoncic et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2006)
Effect of liver regeneration after partial hepatectomy and ischemia-reperfusion on expression of growth factor receptors
P. Baier et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Cisplatin interaction with cysteine and methionine, a theoretical DFT study
T Zimmermann et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling
IK Lund et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2005)
Cisplatin inactivation of caspases inhibits death ligand-induced cell death in Vitro and fulminant liver damage in mice
JN Shin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Biochemical and proteomics approaches to characterize topoisomerase IIα cysteines and DNA as targets responsible for cisplatin-induced inhibition of topoisomerase IIα
BB Hasinoff et al.
MOLECULAR PHARMACOLOGY (2005)
Synthesis and characterization of the biological activity of the cisplatin analogs, cis-PtCl2(dexrazoxane) and cis-PtCl2(levrazoxane), of the topoisomerase II inhibitors dexrazoxane (ICRF-187) and levrazoxane (ICRF-186)
BB Hasinoff et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Kinetic study on the reactions of platinum drugs with glutathione
D Hagrman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Specificity in signal transduction: From phosphotyrosine-SH2 domain interactions to complex cellular systems
T Pawson
CELL (2004)
PTP1B: From the sidelines to the front lines!
NK Tonks
FEBS LETTERS (2003)
Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate
A Salmeen et al.
NATURE (2003)
Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer
I Tegeder et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Cisplatin-induced activation of the EGF receptor
M Benhar et al.
ONCOGENE (2002)
Kinetic study of the reaction of cisplatin with thiols
JC Dabrowiak et al.
DRUG METABOLISM AND DISPOSITION (2002)
Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice
DM Townsend et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Share Paper
